| Year |
Citation |
Score |
| 2004 |
McKie JA, Bhagwat SS, Brady H, Doubleday M, Gayo L, Hickman M, Jalluri RK, Khammungkhune S, Kois A, Mortensen D, Richard N, Sapienza J, Shevlin G, Stein B, Sutherland M. Lead identification of a potent benzopyranone selective estrogen receptor modulator. Bioorganic & Medicinal Chemistry Letters. 14: 3407-10. PMID 15177442 DOI: 10.1016/j.bmcl.2004.04.081 |
0.316 |
|
| 1999 |
Grunewald GL, Caldwell TM, Dahanukar VH, Jalluri RK, Criscione KR. Comparative molecular field analysis (CoMFA) models of phenylethanolamine N-methyltransferase (PNMT) and the alpha2-adrenoceptor: the development of new, highly selective inhibitors of PNMT. Bioorganic & Medicinal Chemistry Letters. 9: 481-6. PMID 10091706 DOI: 10.1016/S0960-894X(99)00022-0 |
0.413 |
|
| 1999 |
Grunewald GL, Dahanukar VH, Jalluri RK, Criscione KR. Synthesis, biochemical evaluation, and classical and three-dimensional quantitative structure-activity relationship studies of 7-substituted-1,2,3,4-tetrahydroisoquinolines and their relative affinities toward phenylethanolamine N-methyltransferase and the alpha2-adrenoceptor. Journal of Medicinal Chemistry. 42: 118-34. PMID 9888838 DOI: 10.1021/Jm980429P |
0.575 |
|
| 1996 |
Victory SF, Vander Velde DG, Jalluri RK, Grunewald GL, Georg GI. Relative stereochemistry and solution conformation of the novel paclitaxel-like antimitotic agent epothilone A Bioorganic and Medicinal Chemistry Letters. 6: 893-898. DOI: 10.1016/0960-894X(96)00139-4 |
0.474 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2023 |
Nguyen MH, Ye HF, Xu Y, Truong L, Horsey A, Zhao P, Styduhar ED, Frascella M, Leffet L, Federowicz K, Behshad E, Wang A, Zhang K, Witten MR, Qi C, ... Jalluri R, et al. Discovery of Orally Bioavailable FGFR2/FGFR3 Dual Inhibitors via Structure-Guided Scaffold Repurposing Approach. Acs Medicinal Chemistry Letters. 14: 312-318. PMID 36923909 DOI: 10.1021/acsmedchemlett.3c00003 |
0.252 |
|
| 2007 |
Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, ... ... Jalluri R, et al. Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer. Journal of Medicinal Chemistry. 50: 603-6. PMID 17256836 DOI: 10.1021/jm061344o |
0.244 |
|
| 1996 |
Moore BM, Jalluri RK, Doughty MB. DNA polymerase photoprobe 2-[(4-azidophenacyl)thio]-2'-deoxyadenosine 5'-triphosphate labels an Escherichia coli DNA polymerase I Klenow fragment substrate binding site. Biochemistry. 35: 11642-51. PMID 8794744 DOI: 10.1021/bi952515m |
0.226 |
|
| 2018 |
Stubbs MC, Burn TC, Sparks RB, Maduskuie T, Diamond S, Rupar M, Wen X, Volgina A, Zolotarjova N, Waeltz P, Favata M, Jalluri R, Liu H, Liu XM, Li J, et al. The Novel Bromodomain and Extraterminal Domain Inhibitor INCB054329 Induces Vulnerabilities in Myeloma Cells That Inform Rational Combination Strategies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30206163 DOI: 10.1158/1078-0432.CCR-18-0098 |
0.186 |
|
| 1999 |
Zaharevitz DW, Gussio R, Wiegand A, Jalluri R, Pattabiraman N, Kellogg GE, Pallansch LA, Yang SS, Buckheit RW. Discovery of novel HIV-1 reverse transcriptase inhibitors using a combination of 3D database searching and 3D QSAR Medicinal Chemistry Research. 9: 551-564. |
0.154 |
|
| 2000 |
Kunick C, Schultz C, Lemcke T, Zaharevitz DW, Gussio R, Jalluri RK, Sausville EA, Leost M, Meijer L. 2-Substituted paullones: CDK1/cyclin B-inhibiting property and in vitro antiproliferative activity. Bioorganic & Medicinal Chemistry Letters. 10: 567-9. PMID 10741555 DOI: 10.1016/S0960-894X(00)00048-2 |
0.139 |
|
| 2022 |
Burns DM, He C, Li YL, Zhuo J, Qian DQ, Chen L, Jalluri R, Diamond S, Covington MB, Li Y, Wynn R, Scherle P, Yeleswaram S, Hollis G, Friedman S, et al. Discovery of a novel 2-spiro-proline steroid mimetic scaffold for the potent inhibition of 11β-HSD1. Bioorganic & Medicinal Chemistry Letters. 128884. PMID 35835377 DOI: 10.1016/j.bmcl.2022.128884 |
0.131 |
|
| 1995 |
Harriman GCB, Jalluri RK, Granewald GL, Vander Velde DG, Georg GI, Himes RH. The chemistry of the taxane diterpene: Stereoselective synthesis of 10-deacetoxy-11,12-epoxypaclitaxel Tetrahedron Letters. 36: 8909-8912. DOI: 10.1016/0040-4039(95)01928-B |
0.129 |
|
| 2007 |
Petrova KV, Jalluri RS, Kozekov ID, Rizzo CJ. Mechanism of 1,N2-etheno-2'-deoxyguanosine formation from epoxyaldehydes. Chemical Research in Toxicology. 20: 1685-92. PMID 17907786 DOI: 10.1021/tx7001433 |
0.117 |
|
| 1994 |
Taylor EW, Ramanathan CS, Jalluri RK, Nadimpalli RG. A basis for new approaches to the chemotherapy of AIDS: novel genes in HIV-1 potentially encode selenoproteins expressed by ribosomal frameshifting and termination suppression. Journal of Medicinal Chemistry. 37: 2637-54. PMID 8064794 |
0.115 |
|
| 2022 |
Zhang C, Xu M, He C, Zhuo J, Burns DM, Qian DQ, Lin Q, Li YL, Chen L, Shi E, Agrios C, Weng L, Sharief V, Jalluri R, Li Y, et al. Discovery of 1'-(1-phenylcyclopropane-carbonyl)-3H-spiro[isobenzofuran-1,3'-pyrrolidin]-3-one as a novel steroid mimetic scaffold for the potent and tissue-specific inhibition of 11β-HSD1 using a scaffold-hopping approach. Bioorganic & Medicinal Chemistry Letters. 128782. PMID 35537608 DOI: 10.1016/j.bmcl.2022.128782 |
0.102 |
|
| 1993 |
Agarwal A, Jalluri RK, DeWitt Blanton C, Taylor EW. A new synthesis of the potent 5-HT1 receptor ligand, 5-carboxyamidotryptamine (5-CT) Synthetic Communications. 23: 1101-1110. DOI: 10.1080/00397919308018587 |
0.099 |
|
| 2014 |
Burns D, Shin N, Jalluri R, Yao W, Scherle P. H4 receptor antagonists and their potential therapeutic applications Annual Reports in Medicinal Chemistry. 49: 135-149. DOI: 10.1016/B978-0-12-800167-7.00010-9 |
0.05 |
|
| Hide low-probability matches. |